HPR87 A Review and Analysis of Medicines Following the Innovative Licensing and Access Pathway (ILAP) in the UK: Does the Pathway Lead to Faster Regulatory Approval and HTA Recommendation?
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1217
https://www.valueinhealthjournal.com/article/S1098-3015(22)03422-2/fulltext
Title :
HPR87 A Review and Analysis of Medicines Following the Innovative Licensing and Access Pathway (ILAP) in the UK: Does the Pathway Lead to Faster Regulatory Approval and HTA Recommendation?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03422-2&doi=10.1016/j.jval.2022.09.1217
First page :
Section Title :
Open access? :
No
Section Order :
10768